Regulation 18 Marking of bottles and other containersI1
Northern Ireland
Subject to paragraph (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked—
in the case of a controlled drug other than a preparation, with the amount of the drug contained therein;
in the case of a controlled drug which is a preparation—
made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container;
not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug.
Nothing in this regulation shall have effect in relation to—
the drugs specified in Schedules 4 and 5 or poppy-straw;
any drug specified in Schedule 3 contained in or comprising a preparation which—
is required for use as a buffering agent in chemical analysis;
has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and
is premixed in a kit;
any exempt product;
the supply of a controlled drug by or on the prescription of a practitioner;
the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals.
In this regulation, the expressions “clinical trial” and “medicinal test on animals” have the same meanings as in the Medicines Act 1968.
Annotations
Commencement
- I1
Reg. 18 in operation at 1.2.2002, see reg. 1